Today
-11.69%
5 Days
-22.00%
1 Month
-50.04%
6 Months
-35.85%
Year to Date
+44.14%
1 Year
+58.15%
• Marvell faced selling pressure due to macroeconomic headwinds and margin scrutiny. • Transition to lower-margin custom chips raised gross margin dilution concerns. • MACD indicates a sell signal while Williams %R suggests oversold conditions.
• Marvell declined due to semiconductor sector weakness and margin dilution concerns. • Custom silicon growth and macroeconomic shifts impacted institutional investor sentiment. • Technical indicators show an oversold condition with an RSI at 33.329.
• Marvell shares fell amid sector-wide risk aversion and semiconductor industry volatility. • The Lumentum acquisition raised shareholder dilution concerns and prompted rating downgrades. • Technical indicators show a sell signal with the MACD at negative 4.348.
• Marvell shares fell amid a sector-wide pullback in semiconductor equities. • The Lumentum acquisition raised institutional concerns regarding potential equity dilution. • Insider share sales and upcoming earnings prompted a defensive investor posture.
• Marvell faced downward pressure amid broader risk-off sentiment in semiconductor equities. • Custom cloud silicon margins and sluggish legacy segments raised investor scrutiny. • Technical indicators show sell signals, while analysts maintain an average price target.
• Marvell surged due to institutional optimism in custom AI silicon and optical interconnects. • Analysts issued Buy ratings with an average price target of $314.95. • The MACD and Williams %R indicators currently suggest a sell signal.
Marvell (MRVL) Fiscal Q2 2027 Earnings Call: FY2028 Outlook Raised to $18 Billion


| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 13.60% |
| Vanguard Capital Management, LLC | 4.47% |
| BlackRock Institutional Trust Company, N.A. | 4.45% |
| Vanguard Portfolio Management, LLC | 3.80% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 50.52% |
| Investment Advisor/Hedge Fund | 20.84% |
| Research Firm | 4.43% |
| Hedge Fund | 2.75% |
Related Instruments